Ovid Therapeutics (OVID) Return on Sales (2020 - 2026)
Ovid Therapeutics' (OVID) quarterly Return on Sales came in at 0.03% in Q1 2026, up 75.0% YoY from 0.02% in Q1 2025, and down 125.21% on a QoQ basis from 0.13% in Q4 2025.
Ovid Therapeutics (OVID) Return on Sales (2020 - 2026) Analysis & Trends
Ovid Therapeutics (OVID) has 7 years of Return on Sales data on file, last reported at 0.03% in Q1 2026.
- Quarterly Return on Sales rose 75.0% year-over-year to 0.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03% (up 42.0% YoY) and the FY2025 annual result came in at 0.02%, up 44.0% from the prior year.
- Return on Sales retreated to 0.03% in Q1 2026, from 0.13% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.5% in Q2 2024 to a low of 10.78% in Q3 2022.
- A 5-year average of 1.39% and a median of 0.81% in 2024 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2022 — Return on Sales slumped 1079 bps — and 2023, when it jumped 975 bps.
- Tracing OVID's Return on Sales over 5 years: stood at 2.49% in 2022, then jumped by 57 bps to 1.08% in 2023, then fell by 13 bps to 1.22% in 2024, then jumped by 111 bps to 0.13% in 2025, then tumbled by 125 bps to 0.03% in 2026.
- The last three Return on Sales figures came in at 0.03% (Q1 2026), 0.13% (Q4 2025), and 0.92% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Ovid Therapeutics | 385.37 Mn | 229.84 Mn | - | -0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.03% |
| Dec 31, 2025 | 0.13% |
| Sep 30, 2025 | -0.92% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.79% |
| Dec 31, 2024 | -1.22% |
| Sep 30, 2024 | -0.81% |
| Jun 30, 2024 | 0.50% |
| Mar 31, 2024 | -0.79% |
| Dec 31, 2023 | -1.08% |
| Sep 30, 2023 | -1.03% |
| Jun 30, 2023 | -1.65% |
| Mar 31, 2023 | -2.02% |
| Dec 31, 2022 | -2.49% |
| Sep 30, 2022 | -10.78% |
| Jun 30, 2022 | -0.47% |
| Mar 31, 2022 | -0.11% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | 0.01% |
| Jun 30, 2021 | 0.01% |